The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
U.S. auto safety regulators said Friday they are investigating if Tesla's recall of more than 2 million vehicles to install new Autopilot safeguards is adequate.